158 related articles for article (PubMed ID: 19655248)
1. Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy.
Barritt AS; Fried MW; Hayashi PH
Dig Dis Sci; 2010 Jun; 55(6):1794-8. PubMed ID: 19655248
[TBL] [Abstract][Full Text] [Related]
2. Images in liver transplantation. Spontaneous portosystemic shunting several years following liver transplantation: successful treatment via percutaneous embolization.
Abujudeh HH; Samanta AK; Cho KC; Klein KM; Bahramipour P; Koneru B
Liver Transpl; 2004 Feb; 10(2):324-6. PubMed ID: 14762875
[No Abstract] [Full Text] [Related]
3. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous portosystemic shunts in noncirrhotic patients presenting with encephalopathy.
Srinivasa RN; Sutphin PD; Anderson ME; Kalva SP
Indian J Gastroenterol; 2015 May; 34(3):256-60. PubMed ID: 26027840
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic encephalopathy: recent developments].
Deltenre P; Moradpour D
Rev Med Suisse; 2014 Sep; 10(440):1612, 1614-6. PubMed ID: 25277000
[TBL] [Abstract][Full Text] [Related]
6. Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy.
Leonard H; O'Beirne J; Yu D; Tsochatzis E
Ann Hepatol; 2014; 13(5):555-7. PubMed ID: 25152989
[No Abstract] [Full Text] [Related]
7. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
8. Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration.
Kawanaka H; Ohta M; Hashizume M; Tomikawa M; Higashi H; Kishihara F; Sugimachi K; Tokumatsu M
Am J Gastroenterol; 1995 Mar; 90(3):508-10. PubMed ID: 7872302
[No Abstract] [Full Text] [Related]
9. Clinical management of type C hepatic encephalopathy.
Ridola L; Riggio O; Gioia S; Faccioli J; Nardelli S
United European Gastroenterol J; 2020 Jun; 8(5):536-543. PubMed ID: 32213035
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.
Huang E; Esrailian E; Spiegel BM
Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and treatment of hepatic encephalopathy].
Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
[TBL] [Abstract][Full Text] [Related]
12. [Radiological studies on the portosystemic shunts in portal-systemic encephalopathy].
Ushiyama M; Ikeda S; Yanagisawa N; Sakai H
Rinsho Shinkeigaku; 1987 Feb; 27(2):151-9. PubMed ID: 3555929
[No Abstract] [Full Text] [Related]
13. Rifaximin for the treatment of hepatic encephalopathy.
Mantry PS; Munsaf S
Transplant Proc; 2010 Dec; 42(10):4543-7. PubMed ID: 21168733
[TBL] [Abstract][Full Text] [Related]
14. Optimal treatment of hepatic encephalopathy.
Waghray A; Waghray N; Kanna S; Mullen K
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Overt Hepatic Encephalopathy.
Sussman NL
Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
Ahire K; Sonawale A
J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
[TBL] [Abstract][Full Text] [Related]
17. Rifaximin in the treatment of chronic hepatic encephalopathy.
Puxeddu A; Quartini M; Massimetti A; Ferrieri A
Curr Med Res Opin; 1995; 13(5):274-81. PubMed ID: 7555036
[TBL] [Abstract][Full Text] [Related]
18. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.
Rivera Ramos JF; Rodríguez Leal C
Ann Hepatol; 2011 Jun; 10 Suppl 2():S36-9. PubMed ID: 22228879
[TBL] [Abstract][Full Text] [Related]
19. Hepatic encephalopathy due to intrahepatic portosystemic venous shunt successfully treated by interventional radiology.
Hiraoka A; Kurose K; Hamada M; Azemoto N; Tokumoto Y; Hirooka M; Hasebe A; Kumagi T; Hirata M; Michitaka K; Minami H; Murakami M; Isobe Y; Horiike N; Onji M
Intern Med; 2005 Mar; 44(3):212-6. PubMed ID: 15805709
[TBL] [Abstract][Full Text] [Related]
20. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
